نتائج البحث

المصدر: PALGA Grp , Hermans , B C M , Derks , J L , Thunnissen , E , van Suylen , R J , den Bakker , M A , Groen , H J M , Smit , E F , Damhuis , R A , van den Broek , E C , Ruland , A , Speel , E J M & Dingemans , A M C 2019 , ' DLL3 expression in large cell neuroendocrine carcinoma (LCNEC) and association with molecular subtypes and neuroendocrine profile ' , Lung Cancer , vol. 138 , pp. 102-108 . https://doi.org/10.1016/j.lungcan.2019.10.010Test

مصطلحات موضوعية: Aged, Biomarkers, Tumor/genetics, Carcinoma, Large Cell/genetics, Neuroendocrine/genetics, Female, Humans, Immunohistochemistry, Intracellular Signaling Peptides and Proteins/biosynthesis, Lung Neoplasms/genetics, Male, Membrane Proteins/biosynthesis, Middle Aged, Mutation, Neoplasm Staging, Prognosis, Retrospective Studies

وصف الملف: application/pdf

العلاقة: https://research.rug.nl/en/publications/9230f217-05d6-4ac8-80cc-5aad7f2cc9d3Test

الإتاحة: https://doi.org/10.1016/j.lungcan.2019.10.010Test
https://hdl.handle.net/11370/9230f217-05d6-4ac8-80cc-5aad7f2cc9d3Test
https://research.rug.nl/en/publications/9230f217-05d6-4ac8-80cc-5aad7f2cc9d3Test
https://pure.rug.nl/ws/files/111704975/DLL3_expression_in_large_cell_neuroendocrine_carcinoma_LCNEC_and_association_with_molecular_subtypes_and_neuroendocrine_profile_Elsevier_Enhanced_Reader.pdfTest

View record in BASE

6

دورية أكاديمية

Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative

المؤلفون: Sasanejad P., Afshar Hezarkhani L., Arsang-Jang S., Tsivgoulis G., Ghoreishi A., Kristian B., Rahmig J., Farhoudi M., Sadeghi Hokmabadi E., Borhani-Haghighi A., Sariaslani P., Sharifi-Razavi A., Ghandehari K., Khosravi A., Smith C., Nilanont Y., Akbari Y., Nguyen T. N., Bersano A., Yassi N., Yoshimoto T., Lattanzi S., Gupta A., Zand R., Rafie S., Pourandokht Mousavian S., Reza Shahsavaripour M., Amini S., Kamenova S. U., Kondybayeva A., Zhanuzakov M., Macri E. M., Nobleza C. O. S., Ruland S., Cervantes-Arslanian A. M., Desai M. J., Ranta A., Moghadam Ahmadi A., Rostamihosseinkhani M., Foroughi R., Hooshmandi E., Akhoundi F. H., Shuaib A., Liebeskind D. S., Siegler J., Romano J. G., Mayer S. A., Bavarsad Shahripour R., Zamani B., Woolsey A., Fazli Y., Mojtaba K., Isaac C. F., Biller J., Di Napoli M., Azarpazhooh M. R.

المساهمون: Sasanejad, P., Afshar Hezarkhani, L., Arsang-Jang, S., Tsivgoulis, G., Ghoreishi, A., Kristian, B., Rahmig, J., Farhoudi, M., Sadeghi Hokmabadi, E., Borhani-Haghighi, A., Sariaslani, P., Sharifi-Razavi, A., Ghandehari, K., Khosravi, A., Smith, C., Nilanont, Y., Akbari, Y., Nguyen, T. N., Bersano, A., Yassi, N., Yoshimoto, T., Lattanzi, S., Gupta, A., Zand, R., Rafie, S., Pourandokht Mousavian, S., Reza Shahsavaripour, M., Amini, S., Kamenova, S. U., Kondybayeva, A., Zhanuzakov, M., Macri, E. M., Nobleza, C. O. S., Ruland, S., Cervantes-Arslanian, A. M., Desai, M. J., Ranta, A., Moghadam Ahmadi, A., Rostamihosseinkhani, M., Foroughi, R., Hooshmandi, E., Akhoundi, F. H., Shuaib, A., Liebeskind, D. S., Siegler, J., Romano, J. G., Mayer, S. A., Bavarsad Shahripour, R., Zamani, B., Woolsey, A., Fazli, Y., Mojtaba, K., Isaac, C. F., Biller, J., Di Napoli, M., Azarpazhooh, M. R.

مصطلحات موضوعية: COVID-19, death, Disability, Longitudinal study, Outcome, Safety, Stroke, Stroke severity, Thrombolytic therapy, Aged, 80 and over, Disability Evaluation, Europe, Female, Fibrinolytic Agent, Hospital Mortality, Human, Infusions, Intravenou, Intracranial Hemorrhage, Iran, Ischemic Stroke, Male, Middle Aged, Risk Assessment, Risk Factor, Time Factor, Treatment Outcome

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34601242; info:eu-repo/semantics/altIdentifier/wos/WOS:000708689400008; volume:30; issue:12; firstpage:106121; journal:JOURNAL OF STROKE AND CEREBROVASCULAR DISEASES; http://hdl.handle.net/11566/298563Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85116060980

الإتاحة: https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106121Test
http://hdl.handle.net/11566/298563Test

View record in BASE

7

Phase II trial of ponatinib in patients with bevacizumab‐refractory glioblastoma

المؤلفون: Jennifer Bruno, Jennifer Stefanik, Sarah C. Gaffey, Brittney Fontana, David A. Reardon, Sandra Ruland, Ugonma Chukwueke, Eudocia Q. Lee, Keith L. Ligon, Dan G. Duda, Debra LaFrankie, Caroline Kane Laub, Rameen Beroukhim, Alona Muzikansky, Patrick Y. Wen, Victoria Caruso, Jorg Dietrich, Lakshmi Nayak, Lisa Doherty

المصدر: Cancer Medicine, Vol 8, Iss 13, Pp 5988-5994 (2019)
Cancer Medicine

مصطلحات موضوعية: Male, Vascular Endothelial Growth Factor A, 0301 basic medicine, Oncology, Cancer Research, Angiogenesis, Basic fibroblast growth factor, Angiogenesis Inhibitors, chemistry.chemical_compound, angiogenesis, 0302 clinical medicine, Clinical endpoint, Original Research, Brain Neoplasms, FGFR, Ponatinib, Imidazoles, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Receptor, TIE-2, Progression-Free Survival, Bevacizumab, Pyridazines, 030220 oncology & carcinogenesis, Cytokines, Female, medicine.drug, Adult, medicine.medical_specialty, lcsh:RC254-282, 03 medical and health sciences, VEGFR, Growth factor receptor, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Karnofsky Performance Status, Protein Kinase Inhibitors, Survival rate, Aged, Vascular Endothelial Growth Factor Receptor-1, business.industry, glioblastoma, Clinical Cancer Research, Vascular Endothelial Growth Factor Receptor-2, 030104 developmental biology, chemistry, Drug Resistance, Neoplasm, Tumor progression, bevacizumab‐refractory, business, Biomarkers

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bec0a793bf5db0eefdfa8ae9c4a9906Test
https://doaj.org/article/57064c00cd29451f907052cc6b3f6e14Test

8

Safety and outcomes of intravenous thrombolytic therapy in ischemic stroke patients with COVID-19: CASCADE initiative

المؤلفون: Anna M. Cervantes-Arslanian, Mohammad Reza Shahsavaripour, Mahtab Rostamihosseinkhani, Elizabeth Macri, Mario Di Napoli, James E. Siegler, Amir Moghadam Ahmadi, José Biller, Christian F Isaac, Seyede Pourandokht Mousavian, Stephan A. Mayer, Saltanat Kamenova, Amadene Woolsey, Abdoreza Ghoreishi, Annemarei Ranta, Sean Ruland, Jan Rahmig, Shahram Amini, Yama Akbari, Craig J. Smith, Kavian Ghandehari, Athena Sharifi-Razavi, Alireza Khosravi, Jose G. Romano, Georgios Tsivgoulis, Christa O'Hana S. Nobleza, Elyar Sadeghi Hokmabadi, Takeshi Yoshimoto, Afshin Borhani-Haghighi, Anna Bersano, Shahram Arsang-Jang, Fahimeh Haji Akhoundi, Simona Lattanzi, Murat Zhanuzakov, Barlinn Kristian, Leila Afshar Hezarkhani, Nawaf Yassi, Payam Sasanejad, Ashfaq Shuaib, Masoom Desai, Payam Sariaslani, Yasaman Fazli, Reza Bavarsad Shahripour, Shahram Rafie, Mehdi Farhoudi, Babak Zamani, Khazaei Mojtaba, Ramin Zand, Thanh N. Nguyen, Razieh Foroughi, David S Liebeskind, Animesh Gupta, Aida Kondybayeva, Yongchai Nilanont, Etrat Hooshmandi, M. Reza Azarpazhooh

المصدر: Journal of Stroke and Cerebrovascular Diseases
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, vol 30, iss 12
Sasanejad, P, Afshar Hezarkhani, L, Arsang-jang, S, Tsivgoulis, G, Ghoreishi, A, Kristian, B, Rahmig, J, Farhoudi, M, Sadeghi Hokmabadi, E, Borhani-haghighi, A, Sariaslani, P, Sharifi-razavi, A, Ghandehari, K, Khosravi, A, Smith, C, Nilanont, Y, Akbari, Y, Nguyen, T N, Bersano, A, Yassi, N, Yoshimoto, T, Lattanzi, S, Gupta, A, Zand, R, Rafie, S, Pourandokht Mousavian, S, Reza Shahsavaripour, M, Amini, S, Kamenova, S U, Kondybayeva, A, Zhanuzakov, M, Macri, E M, Nobleza, C O S, Ruland, S, Cervantes-arslanian, A M, Desai, M J, Ranta, A, Moghadam Ahmadi, A, Rostamihosseinkhani, M, Foroughi, R, Hooshmandi, E, Akhoundi, F H, Shuaib, A, Liebeskind, D S, Siegler, J, Romano, J G, Mayer, S A, Bavarsad, R, Zamani, B, Woolsey, A, Fazli, Y, Mojtaba, K, Isaac, C F, Biller, J, Di Napoli, M & Azarpazhooh, M R 2021, ' Safety and outcomes of intravenous thrombolytic therapy in ischemic stroke patients with COVID-19: CASCADE initiative ', Journal of Stroke and Cerebrovascular Diseases . https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106121Test

مصطلحات موضوعية: Male, Longitudinal study, Time Factors, Iran, outcomes, Disability Evaluation, Modified Rankin Scale, Risk Factors, 80 and over, Thrombolytic Therapy, Hospital Mortality, Infusions, Intravenous, Stroke, thrombolytic therapy, Aged, 80 and over, Rehabilitation, Confounding, longitudinal study, stroke severity, Middle Aged, Europe, Stroke severity, Treatment Outcome, Cohort, Female, Safety, Cardiology and Cardiovascular Medicine, Intravenous, Intracranial Hemorrhages, COVID 19, safety, medicine.medical_specialty, Infusions, Coronavirus disease 2019 (COVID-19), Clinical Sciences, Outcomes, Risk Assessment, Article, Fibrinolytic Agents, Clinical Research, Internal medicine, death, medicine, Humans, Aged, Ischemic Stroke, Disability, Neurology & Neurosurgery, business.industry, Neurosciences, COVID-19, Odds ratio, medicine.disease, Brain Disorders, Good Health and Well Being, disability, Ischemic stroke, Surgery, Neurology (clinical), business